Vivani Medical VANI Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost at other companies
Other financials
Where this comes from
Reported directly by Vivani Medical in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost.
The official record: Vivani Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vivani Medical's deferred tax assets, tax deferred expense, compensation and benefits, share-based compensation cost.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vivani Medical's deferred tax assets, tax deferred expense, compensation and benefits, share-based compensation cost?
- Vivani Medical (VANI) reported deferred tax assets, tax deferred expense, compensation and benefits, share-based compensation cost of $2.41M in Q4 2025.
- How has Vivani Medical's deferred tax assets, tax deferred expense, compensation and benefits, share-based compensation cost changed year-over-year?
- Vivani Medical's deferred tax assets, tax deferred expense, compensation and benefits, share-based compensation cost increased by 20.8% year-over-year, from $1.99M to $2.41M.
- What is the long-term trend for Vivani Medical's deferred tax assets, tax deferred expense, compensation and benefits, share-based compensation cost?
- Over 5 years (2020 to 2025), Vivani Medical's deferred tax assets, tax deferred expense, compensation and benefits, share-based compensation cost has grown at a 44.7% compound annual growth rate (CAGR), from $380K to $2.41M.